Publications by authors named "Helmut Petto"

Claim this Profile
B
Baricitinib provides rapid and sustained improvements in absolute EASI and SCORAD outcomes in adults with moderate-to-severe atopic dermatitis.
Jacob P Thyssen, Thomas Bieber, C Elise Kleyn, Audrey Nosbaum, Susanne Grond, Helmut Petto

J Dermatolog Treat· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect Treatment Comparison of Baricitinib versus Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis.
Marjolein S de Bruin-Weller, Esther Serra-Baldrich, Sebastien Barbarot, Susanne Grond, Christopher Schuster, Helmut Petto

Dermatol Ther (Heidelb)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a new method for potential use of Psoriasis Area and Severity Index in teledermatology.
Jason Wu, Helmut Petto, Yves Dutronc, Nicole Burkhardt, Kurt Gebauer

Australas J Dermatol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A statistical method to convert published response rates into marginal distributions with an example application in psoriasis.
Helmut Petto, Ulrich Mrowietz, Stefan Wilhelm, Alexander Schacht

Pharm Stat· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator.
Helmut Petto, Zbigniew Kadziola, Alan Brnabic, Daniel Saure, Mark Belger

Value Health· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Teriparatide in Patients with Osteoporosis in Clinical Practice: 42-Month Results During and After Discontinuation of Treatment from the European Extended Forsteo® Observational Study (ExFOS).
Nicola Napoli, Bente L Langdahl, Östen Ljunggren, Eric Lespessailles, George Kapetanos, Helmut Petto

Calcif Tissue Int· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Teriparatide or Risedronate in Elderly Patients With a Recent Pertrochanteric Hip Fracture: Final Results of a 78-Week Randomized Clinical Trial.
Jorge Malouf-Sierra, Umberto Tarantino, Pedro A García-Hernández, Costantino Corradini, Søren Overgaard, Helmut Petto

J Bone Miner Res· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Teriparatide Compared with Risedronate on Recovery After Pertrochanteric Hip Fracture: Results of a Randomized, Active-Controlled, Double-Blind Clinical Trial at 26 Weeks.
Per Aspenberg, Jorge Malouf, Umberto Tarantino, Pedro A García-Hernández, Costantino Corradini, Helmut Petto

J Bone Joint Surg Am· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fracture Rate, Quality of Life and Back Pain in Patients with Osteoporosis Treated with Teriparatide: 24-Month Results from the Extended Forsteo Observational Study (ExFOS).
Bente L Langdahl, Östen Ljunggren, Claude-Laurent Benhamou, Fernando Marin, George Kapetanos, Helmut Petto

Calcif Tissue Int· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of cancellous bone microstructure in patients on teriparatide following alendronate pretreatment.
Astrid Fahrleitner-Pammer, David Burr, Harald Dobnig, Jan J Stepan, Helmut Petto

Bone· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stage.
Luis A Vázquez, Ángel Rodríguez, Javier Salvador, Juan F Ascaso, Helmut Petto

BMC Cardiovasc Disord· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment persistence and changes in fracture risk, back pain, and quality of life amongst patients treated with teriparatide in routine clinical care in France: results from the European Forsteo Observational Study.
Gerald Rajzbaum, Franck Grados, David Evans, Soyi Liu-Leage, Helmut Petto

Joint Bone Spine· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial.
Claus-C Glüer, Fernando Marin, Johann D Ringe, Federico Hawkins, Rüdiger Möricke, Helmut Petto

J Bone Miner Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High resolution quantitative computed tomography-based assessment of trabecular microstructure and strength estimates by finite-element analysis of the spine, but not DXA, reflects vertebral fracture status in men with glucocorticoid-induced osteoporosis.
Christian Graeff, Fernando Marin, Helmut Petto, Ole Kayser, Andreas Reisinger

Bone· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patients with Type 2 Diabetes Initiating Exenatide Twice Daily or Insulin in Clinical Practice: CHOICE Study.
Stephan Matthaei, Matthew Reaney, Chantal Mathieu, Claes-Göran Ostenson, Thure Krarup, Helmut Petto

Diabetes Ther· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exenatide twice daily versus premixed insulin aspart 70/30 in metformin-treated patients with type 2 diabetes: a randomized 26-week study on glycemic control and hypoglycemia.
Baptist Gallwitz, Michael Böhmer, Thomas Segiet, Andrea Mölle, Karsten Milek, Helmut Petto

Diabetes Care· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teriparatide reduces bone microdamage accumulation in postmenopausal women previously treated with alendronate.
Harald Dobnig, Jan J Stepan, David B Burr, Jiliang Li, Dana Michalská, Helmut Petto

J Bone Miner Res· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.
Jan J Stepan, David B Burr, Imre Pavo, Adrien Sipos, Dana Michalska, Helmut Petto

Bone· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of tadalafil efficacy in men with erectile dysfunction: the SURE study comparing two dosing regimens.
Pierre Costa, Jacques Buvat, Simon Holmes, Sabine Weitckus, Helmut Petto

J Sex Med· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis